VCRE
Vicore Pharma Holding AB
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$8.85
+1.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3930.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 28.10x
- Price / sales
- 1860.33x
- Price / cash flow
- -10.95x
Enterprise value
- Enterprise value
- $239.7M
- EV / sales
- 1790.10x
- EV / EBITDA
- -9.57x
- EV / EBIT
- -8.34x
- Market cap
- $249.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026